Twenty years ago, during the height of the AIDS epidemic, K-PAX Pharmaceuticals began studying and testing ways to improve immune function. After many years of refinement and clinical testing, we have identified a micronutrient formula that supports increased energy production at the cellular level. 

A large pharmaceutical company (Bristol-Myers Squibb) then funded a double-blinded, placebo-controlled research study of our Immune Support Formula in people with HIV/AIDS.

This research study showed that K-PAX Immune Support Formula could strengthen the immune systems in these individuals and the results were published in The Journal of AIDS in August 2006. {JAIDS 2006;42(5):523-528}

The publication of these research results led to a ground breaking event ->Insurance coverage of K-PAX Immune Support Products by Medicaid and The AIDS Drug Assistance Program (ADAP) in New York State.

K-PAX's founder, Jon Kaiser, M.D., has twenty years of clinical experience testing successful micronutrient formulas as complementary treatments in patients with difficult to treat conditions such as Cancer, HIV/AIDS, and Chronic Fatigue Syndrome.

In addition to seeking FDA approval for our Immune Support Formula as a complementary treatment for HIV/AIDS, K-PAX is currently performing groundbreaking research on a new treatment for Chronic Fatigue Syndrome (CFS). K-PAX ENERGY is our over-the-counter version of the prescription treatment we believe will eventually receive FDA approval as the first safe and effective treatment for CFS..

If your energy is low or if your immune system needs strengthening, consider joining the thousands of people currently benefiting from K-PAX products. We wish you good health and a long life!